Reprogrammed Interchange LLC sold $1.6M of VOR
owner at Vor Biopharma Inc.. 41,752 shares at an average of $39.43, traded Oct 1, 2025, filed Oct 3, 2025.
Score components
- +12Role10% owner
- +25Trade size$1.6M at market
- 0Share of holdings soldSold 2.5% of holdings
- +8Cluster2 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -35.6%, 3m -68.9%, 6m -51.8%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0002050755-25-000009, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 1, 2025 | SOpen-market sale Common Stock | -1,400 | $39.19 | $55k | 1,637,660 | Oct 3, 2025 |
| Oct 2, 2025 | SOpen-market sale Common Stock | -4,937 | $37.21 | $184k | 1,632,723 | Oct 3, 2025 |
| Oct 2, 2025 | SOpen-market sale Common Stock | -1,513 | $38.38 | $58k | 1,631,210 | Oct 3, 2025 |
| Oct 2, 2025 | SOpen-market sale Common Stock | -7,700 | $39.57 | $305k | 1,623,510 | Oct 3, 2025 |
| Oct 2, 2025 | SOpen-market sale Common Stock | -13,001 | $40.13 | $522k | 1,610,509 | Oct 3, 2025 |
| Oct 2, 2025 | SOpen-market sale Common Stock | -5,300 | $42.32 | $224k | 1,605,209 | Oct 3, 2025 |
| Oct 3, 2025 | SOpen-market sale Common Stock | -3,200 | $37.37 | $120k | 1,602,009 | Oct 3, 2025 |
| Oct 3, 2025 | SOpen-market sale Common Stock | -4,701 | $38.14 | $179k | 1,597,308 | Oct 3, 2025 |
Related signals
Other insiders at Vor Biopharma Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 12Weak | VORsell Vor Biopharma Inc. | Ra Capital Management, L.p. owner | $4,207 213 shares | -0% | |
| 40Moderate | VORsell Vor Biopharma Inc. | Ra Capital Management, L.p. director, owner | $2.6M 165,150 shares | -6% | |
| 45Moderate | VORsell Vor Biopharma Inc. | Ra Capital Management, L.p. director, owner | $10M 630,374 shares | -20% | |
| 45Moderate | VORsell Vor Biopharma Inc. | Ra Capital Management, L.p. director, owner | $12M 737,989 shares | -19% | |
| 45Moderate | VORsell Vor Biopharma Inc. | Ra Capital Management, L.p. director, owner | $10M 620,133 shares | -14% | |
| 45Moderate | VORsell Vor Biopharma Inc. | Ra Capital Management, L.p. director, owner | $15M 849,257 shares | -16% | |
| 58Moderate | Vor Biopharma Inc. | Ra Capital Management, L.p. director, owner | $10M 400,408 shares | -34% | |
| 53Moderate | Vor Biopharma Inc. | Ra Capital Management, L.p. director, owner | $6.2M 221,166 shares | -16% | |
| 48Moderate | Vor Biopharma Inc. | Ra Capital Management, L.p. director, owner | $3.4M 117,050 shares | -8% | |
| 45Moderate | Vor Biopharma Inc. | Reprogrammed Interchange LLC owner | $1.1M 37,533 shares | -3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.